Marcio Diniz, PhD
img_Marcio Diniz
ASSOCIATE PROFESSOR | Population Health Science and Policy

Statistics, University of São Paulo

Publications

Selected Publications

Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial. Anjali Chauhan, Eunyoung Angela Lee, Rakesh B. Patel, Mariia Kumskova, Enrique C. Leira, Anil K. Chauhan, Yanrong Shi, Suyi Cao, Raymond C. Koehler, Krishnan M. Dhandapani, Mohammad Badruzzaman Khan, Pradip K. Kamat, Ali Arbab, David C. Hess, Alison L. Herman, Ligia Boisserand, Lauren H. Sansing, Andreia Morais, Xuyan Jin, Sanem Aykan, Takahiko Imai, Cenk Ayata, Karisma A. Nagarkatti, Jessica Lamb, Márcio A. Diniz, Patrick D. Lyden, Louise D. McCullough, Jaroslaw Aronowski. Neuropharmacology

Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity. Ioannis Evangelos Louloudis, Yi Bin Chen, Nikolaos Spyrou, Amin Alousi, Nikolaos Katsivelos, Francis Ayuk, Daniela Weber, William J. Hogan, Aaron M. Etra, Muna Qayed, Paibel Aguayo-Hiraldo, Yu Akahoshi, Monzr M.Al Malki, Javier Bolaños-Meade, Chantiya Chanswangphuwana, Marcio Diniz, Matthias Eder, Elizabeth Hexner, Carrie L. Kitko, Sabrina Kraus, Pietro Merli, Timothy Olson, Margaret L. MacMillan, Joseph Pidala, Ran Reshef, Tal Schechter, Matthias Wölfl, Janna Baez, Gilbert Eng, Sigrun Gleich, Rachel Young, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine. Transplantation and Cellular Therapy

A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors. Bruna Taciane da Silva Bortoleti, Sophia Quasem, Stefanie Maurer, Xiaoxuan Zhong, Ruan Pimenta, Luiza Ribeiro de Lima Brandão, Matthew Hernandez, Melanie Fraidenburg, Pedro Henrique Alves da Silva, Raymond Alvarez, Benjamin K. Chen, Márcio Augusto Diniz, Brian Housman, Raja M. Flores, Rachel Brody, Thomas U. Marron, Lucas Ferrari de Andrade. Nature Communications

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Diniz during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bloomer Health Tech Inc
  • Comanche Biopharma

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.